newsfilter
← Latest News
GlobeNewswire·

Sanofi : Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion

Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion Proprietary immuno-oncology (IO) platform synergistic with Sanofi’s existing therapeutic platforms Lead...